PFIZER-MYLAN COMBO VIATRIS TO REDUCE WORKFORCE BY 9,000

Highlights

• In the month of November, the US pharmaceutical giant Pfizer had joined hands with Mylan to create generics business Viatris

• As per the plan, Viatris by the year 2024 has a target of raising a minimum of $1 billion from its cost base, and it’s planning to shut down or divest nearly 15 facilities to reach there

• The company said the layoffs will be taking place in phases over th....